Praxis Precision Medicines
Clinical trials sponsored by Praxis Precision Medicines, explained in plain language.
-
Epilepsy drug safety test expands to 700 patients
Disease control ENROLLING_BY_INVITATIONThis study continues testing vormatrigine, an investigational medication for epilepsy, to evaluate its long-term safety in adults. It enrolls 700 participants who previously took vormatrigine in earlier trials and continue taking it to control their seizures. The main goal is to …
Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Apr 02, 2026 05:12 UTC
-
New hope for steady hands: major trial tests promising tremor drug
Disease control ENROLLING_BY_INVITATIONThis large, late-stage study aims to find out if a new drug called ulixacaltamide is safe and effective for controlling essential tremor, a condition that causes shaky hands. About 1,000 adults with essential tremor will participate in different parts of the study, some receiving…
Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for kids with devastating seizure disorders
Disease control OngoingThis study is testing an investigational drug called PRAX-562 to see if it is safe and can help reduce seizures in children with rare, severe forms of epilepsy caused by specific genetic changes (SCN2A or SCN8A). Children in the study will first receive either the drug or a place…
Phase: PHASE2, PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC